| Rockwell Medical Begins Second Phase III Clinical Trial for Treatment of Iron ... - Review seeker (press release) |
|
|
Review seeker (press release) By Globenewswire WIXOM, Mich., April 26, 2011 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease |